Observational studyDiabetologia2024

Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care.

Gian Paolo Fadini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.